Novartis Ag (NVS) Non-cash Items (2009 - 2025)

Novartis Ag (NVS) has 12 years of Non-cash Items data on file, last reported at $5.7 billion in Q2 2025.

• Quarterly Non-cash Items rose 136.08% year-over-year to $5.7 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $5.7 billion (up 136.08% YoY) and the FY2025 annual result came in at $11.2 billion, up 129.3% from the prior year.
• Non-cash Items climbed to $5.7 billion in Q2 2025 per NVS's latest filing, from $4.9 billion in the prior quarter.
• The five-year high for Non-cash Items was $5.7 billion in Q2 2025, with the low at $1.9 billion in Q2 2021.
• Average Non-cash Items over 5 years is $3.9 billion, with a median of $4.3 billion recorded in 2021.
• Year-over-year, Non-cash Items decreased 18.98% in 2021 and jumped 136.08% in 2025.
• Novartis Ag's Non-cash Items stood at $4.3 billion in 2021, then increased by 26.91% to $5.4 billion in 2022, then slipped by 3.05% to $5.2 billion in 2023, then dropped by 6.71% to $4.9 billion in 2024, then climbed by 15.7% to $5.7 billion in 2025.
• Business Quant data shows NVS's Non-cash Items at $5.7 billion in Q2 2025, $4.9 billion in Q4 2024, and $2.4 billion in Q2 2024.